Geopolitics Alpha

Trulieve Cannabis (TRLV) Could Be 43% Undervalued Following Its Latest Earnings Report

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHATrulieve Cannabis (TRLV) Could Be43% Undervalued Following ItsLatest Earnings ReportTRLVGEOPOLITICS ALPHA

This report does not map to a usual set of affected companies.

Directly affected

  • TRLV Trulieve Cannabis

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Trulieve Cannabis belongs to, so it often moves with news about it.

  • DFTX Definium Therapeutics-13.3% 30d

    Definium Therapeutics is a peer of Trulieve Cannabis in medicinal chemicals and botanical products; rivals often move on the same news.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a large health company like Trulieve Cannabis; big names in a sector often move together.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a large health company like Trulieve Cannabis; big names in a sector often move together.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a large health company like Trulieve Cannabis; big names in a sector often move together.

  • MRK Merck+3.5% 30d

    Merck is a large health company like Trulieve Cannabis; big names in a sector often move together.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
TRLV+7.11%+8.08%baseafter closeafter closeafter closeafter close
XLV+0.52%-0.04%baseafter closeafter closeafter closeafter close
DFTX+14.83%+9.46%baseafter closeafter closeafter closeafter close
LLY-0.12%-0.28%baseafter closeafter closeafter closeafter close
JNJ-0.65%+0.33%baseafter closeafter closeafter closeafter close
ABBV-0.23%-0.02%baseafter closeafter closeafter closeafter close
MRK+2.39%+1.67%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Trulieve Cannabis (TRLV) Could Be 43% Undervalued Following Its Latest Earnings Report Yahoo! Finance Canada

Source: Yahoo Finance

This story

CompanyWhenMoveStatus
ABBVthree days earlier-0.02%final price
ABBVfive days earlier-0.23%final price
DFTXthree days earlier+9.46%final price
DFTXfive days earlier+14.83%final price
JNJthree days earlier+0.33%final price
JNJfive days earlier-0.65%final price
LLYthree days earlier-0.28%final price
LLYfive days earlier-0.12%final price
MRKthree days earlier+1.67%final price
MRKfive days earlier+2.39%final price
TRLVthree days earlier+8.08%final price
TRLVfive days earlier+7.11%final price
XLVthree days earlier-0.04%final price
XLVfive days earlier+0.52%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Trulieve Cannabis (TRLV) Could Be 43% Undervalued Following Its Latest Earnings Report” scores 12 out of 100. The score uses 1 sources.